Dr Reddys Labs` Generic Doxycycline Receives Approval in the U.S
AUS National Institutes of Health (NIH)-funded study has reported that the oral antibiotic doxycycline prevented sexually transmitted infections (STIs) acquisition by two-thirds. nnResearchers at the University of Washington, Seattle and the University of California at San Francisco (UCSF) led the trial. nnAt total of 501 adults aged at least 18 years were enrolled at four clinic sites in San Francisco and Seattle. nnPartner Content nnA guide to managing hazardous waterborne bacteria outbreaks nAn outbreak of hazardous bacteria can happen in any healthcare facility, even with preventative measures in place. When an outbreak occurs, timely and effective action is vital to protect patients and staff and maintain the facility’s reputation. A good water… nnBy Pall nIn the trial, 174 participants were living with HIV and 327 were taking HIV PrEP medications. nnPublished in the New England Journal of Medicine, the findings showed that the oral antibiotic prevented STIs in men, who took the medication within 72 hours of having condomless sex, with men and transgender women. nnThe post-exposure approach, which is termed as doxy-PEP, specifically resulted in a two-thirds reduction in the chlamydia, syphilis, and gonorrhea in the study participants, who were reported to have STI within the previous year. nnThe researchers noted that a slight increase in antibacterial resistance was found in the study that needs further exploration. nnUCSF Zuckerberg San Francisco General Hospital infectious diseases professor Annie Luetkemeyer said: “Given its demonstrated efficacy in several trials, doxy-PEP should be considered as part of a sexual health package for men who have sex with men and transwomen if they have an increased risk of STIs.
Lupin's Generic Doxycycline Receives Approval in the U.S.
A significant proportion of bacterial sexually transmitted infections (STIs) – gonorrhea, chlamydia, or syphilis – were prevented with a dose of doxycycline after unprotected sex, according to preliminary results of a clinical trial that closed early because it was very effective for men who have sex with men and transgender women who are living with HIV or are taking HIV pre-exposure prophylaxis (PrEP).
(Reuters) - A UK trial found that commonly used antibiotics azithromycin and doxycycline were generally not effective as a treatment for early stages of COVID-19 in order to prevent hospitalisation or further intervention, Oxford University said on Monday.
Australian triple therapy specialist Professor Thomas Borody, internationally famous for curing peptic ulcers using a triple antibiotic therapy saving thousands of lives, said 34 prescriptions for the inexpensive low-dose Ivermectin Triple Therapy 10-day treatment protocol have been written by GPs.
Fusion Health Care, a pharma company based at Hyderabad, has announced the launch of its favipiravir drug under the brand name XARAVIR, for the treatment of mild to moderate COVID-19 cases.